Genomic DNA Methylation Status and Plasma Homocysteine in Choline- and Folate-Deficient Rats.
- Author:
Ju Ae MUN
1
;
Hyesun MIN
Author Information
1. Department of Food and Nutrition, College of Bio-Nano Science, Hannam University, Daejeon 306-791, Korea. hsmin@hannam.ac.kr
- Publication Type:Original Article
- Keywords:
choline;
folate;
homocyteine;
S-adenosylmethionine;
DNA methylation
- MeSH:
Adult;
Alzheimer Disease;
Animals;
Betaine;
Brain;
Choline;
Choline Deficiency;
Diet;
DNA Methylation*;
DNA*;
Folic Acid;
Homocysteine*;
Humans;
Liver;
Male;
Metabolism;
Methionine;
Methylation;
Nervous System;
Plasma*;
Rats*;
Rats, Sprague-Dawley;
Risk Factors;
S-Adenosylhomocysteine;
S-Adenosylmethionine
- From:The Korean Journal of Nutrition
2007;40(1):14-23
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Elevated plasma homocysteine ( Hcy) is a risk factor for cognitive dysfunction and Alzheimer disease, although the mechanism is still unknown. Both folate and betaine, a choline metabolite, play essential roles in the remethylation of Hcy to methionine. Choline deficiency may be associated with low folate status and high plasma Hcy. Alterations in DNA methylation also have established critical roles for methylation in development of the nervous system. This study was un-dertaken to assess the effect of choline and folate deficiency on Hcy metabolism and genomic DNA methylation status of the liver and brain. Groups of adult male Sprague Dawley rats were fed on a control, choline-deficient ( CD) , folate-deficient ( FD) or choline/folate-deficient ( CFD) diets for 8 weeks. FD resulted in a significantly lower hepatic folate ( 23%)(p < 0.001) and brain folate ( 69%)(p < 0.05) compared to the control group. However, plasma and brain folate remained unaltered by CD and hepatic folate reduced to 85% of the control by CD ( p < 0.05) . Plasma Hcy was signi-ficantly increased by FD ( 18.34 +/- 1.62 micrometer) and CFD ( 19.35 +/-3.62 micrometer) compared to the control ( 6.29 +/-0.60 micrometer) ( p < 0.001) , but remained unaltered by CD. FD depressed S-adenosylmethionine ( SAM) by 59% ( p < 0.001) and ele-vated S-adenosylhomocysteine ( SAH) by 47% in liver compared to the control group ( p < 0.001) . In contrast, brain SAM levels remained unaltered in CD, FD and CFD rats. Genomic DNA methylation status was reduced by FD in liver ( p< 0.05) . Genomic DNA hypomethylation was also observed in brain by CD, FD and CFD although it was not signifi-cantly different from the control group. Genomic DNA methylation status was correlated with folate stores in liver ( r = - 0.397, p < 0.05) and brain ( r = - 0.390, p < 0.05) , respectively. In conclusion, our data demonstrated that genomic DNA methylation and SAM level were reduced by folate deficiency in liver, but not in brain, and correlated with folate concentration in the tissue. The fact that folate deficiency had differential effects on SAM, SAH and genomic DNA methylation in liver and brain suggests that the Hcy metabolism and DNA methylation are regulated in tissue-specific ways.
